A Dream report details attacks on 24 PAN-OS firewalls and a related network server, while saying AI use in the exploit chain is unproven.
Could AI Have Helped With The PHP2Shell Chain? A Palo Alto Case Study
The Latest
What To Watch After DeepSeek’s Reported $16 Billion Raise
Reports put DeepSeek’s second funding round at up to 106 billion yuan, but the company has not confirmed the amount, investors or ownership changes.
When An AI Refusal Meets Religious Accommodation Law
The University of Kentucky approved Humanist David Durman’s request not to personally use AI at work, an individual accommodation, not a court ruling.
ChatGPT Pro Update: What’s Included After The Pro 200 Cut
OpenAI canceled a planned Pro 200 allowance reduction and increased Work and Codex usage for Pro 100, Pro 200 and Pro 500 subscribers.
The AI Agent Economy’s Foundation: Four Deals In One Day
Four developments on Oct. 29 point to investment in the infrastructure around AI agents, from open-source voice tools to identity and design.
Amazon’s Cash-Fueled AWS Growth: The AI Investment Behind The Numbers
AWS revenue rose 39% in Q3, but Amazon’s $75.9 billion quarterly capital spending and weaker-than-expected results weighed on shares.
Using AI To Turn Case Information Into Investigation Reports
A proposed AI workflow would turn investigators’ notes, photos and GPS logs into draft reports, with human review and legal validation still needed.
Three Departures In Four Months: ByteDance GenAI R&D Head Resigns
A 36Kr headline reports the leader is moving to embodied intelligence and says three core members have left in four months; details remain sparse.
15 Best Router Firewall Appliances for Home Networks in 2027
Compare 15 home network router firewall appliances, from simple gateways to multi-gig mini PCs, and find the right fit for your security and setup needs.
How Gemini Is Helping Students And Teachers In The Classroom
Google reports UK math-tutoring and Italian classroom studies of Gemini, with gains on quizzes but no measurable STAR test improvement in the 10-week trial.
